Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1978801 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL1095723 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL4100169 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL133456 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL6021620 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL23038765 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL4635532 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL4582497 | 1.00 | DNM1 (0.48) | DNM1USP2HTTTSHRMEN1 | |
| SCHEMBL1095934 | 0.98 | DNM1 (0.45) | DNM1USP2HTTTSHRMEN1 | |
| Ethylene Glycol SCHEMBL15090416 | 0.94 | MEN1 (0.47) | DNM1USP2HTTTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119837772-A | Repair nano emulsion and preparation method thereof | 广东鼎尖国际生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-116869844-A | Sun cream and preparation method thereof | 福州萍晴日用化妆品有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-122080069-A | Phospholipid compounds and uses thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-119837772-A | Repair nano emulsion and preparation method thereof | 广东鼎尖国际生物科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119837772-A | Repair nano emulsion and preparation method thereof | 广东鼎尖国际生物科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-118019547-A | Thermostable lipid nanoparticles and methods of use thereof | 默沙东有限责任公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-116869844-A | Sun cream and preparation method thereof | 福州萍晴日用化妆品有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-116869844-A | Sun cream and preparation method thereof | 福州萍晴日用化妆品有限公司 | 2023-10-13 | — | — | CN | disclosed |
| EP-4200301-A1 | PHOSPHOLIPID COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2023-06-28 | — | — | EP | disclosed |
| WO-2022046631-A1 | PHOSPHOLIPID COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| CN-100344677-C | Gel composition | PANRICO PARTNERSHIP INC (US) | 2007-10-24 | — | — | CN | disclosed |
| EP-1742661-A2 | LIPID COMPOSITIONS AND USE THEREOF | Neopharm, Inc. (US) | 2007-01-17 | — | — | EP | disclosed |
| US-20050277611-A1 | Cationic cardiolipin analoges and its use thereof | NEOPHARM, INC. (US) | 2005-12-15 | — | — | US | disclosed |
| EP-1558562-A1 | CATIONIC CARDIOLIPIN ANALOGS AND USE THEREOF | Neopharm, Inc. (US) | 2005-08-03 | — | — | EP | disclosed |
| WO-2005067632-A2 | LIPID COMPOSITIONS AND USE THEREOF | NEOPHARM, INC. (US) | 2005-07-28 | — | — | WO | disclosed |
| CN-1174037-C | Gel composition | �����ɺϻ﹫˾ | 2004-11-03 | — | — | CN | disclosed |
| WO-2004035523-A1 | CATIONIC CARDIOLIPIN ANALOGS AND USE THEREOF | NEOPHARM, INC. (US) | 2004-04-29 | — | — | WO | disclosed |
| CN-1385457-A | Gel composition | PANRICO PARTNERSHIP INC (US) | 2002-12-18 | — | — | CN | disclosed |
| CN-1324380-A | Gel composition | PENRECO (US) | 2001-11-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277611-A1 | Cationic cardiolipin analoges and its use thereof | LCLAT1, CETP, LIPA | DNM1 707/4885USP2 4112/4885HTT 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.